Circadian rhythm of urinary potassium excretion in patients with CKD

Toshiyuki Miura1, Michio Fukuda, Takehiro Naito

  • 1Department of Cardio-Renal Medicine and Hypertension, Nagoya City University Graduate School of Medical Sciences, Nagoya 467-8601, Japan.

Clinical Nephrology
|August 10, 2012
PubMed

Insights

The circadian rhythm of urinary potassium excretion in chronic kidney disease (CKD) patients is linked to sodium excretion, not renal function or blood pressure. This finding highlights a new aspect of electrolyte balance in CKD.

Area of Science:

  • Nephrology
  • Chronobiology
  • Physiology

Background:

  • Previous research indicated impaired circadian rhythms of blood pressure and urinary sodium excretion in chronic kidney disease (CKD) patients.
  • The circadian rhythm of urinary potassium excretion in relation to renal dysfunction remained unstudied.

Purpose of the Study:

  • To investigate the relationship between the circadian rhythm of urinary potassium excretion and renal function in CKD patients.
  • To explore the determinants of the circadian rhythm of urinary potassium excretion, including renal function, blood pressure, and urinary sodium excretion.

Main Methods:

  • Evaluated daytime and nighttime urinary excretion rates of sodium (UNaV) and potassium (UKV) in 83 CKD subjects.
  • Estimated circadian rhythms using night/day ratios for BP, UNaV, and UKV.
  • Employed multiple regression analysis to identify independent predictors of UKV circadian rhythm.

Main Results:

  • Night/day ratios of both UNaV and UKV increased with deteriorating renal function.
  • The night/day ratio of UKV was positively correlated with the night/day ratio of UNaV (r = 0.60, p < 0.0001).
  • Multiple regression analysis indicated that the night/day ratio of UKV was independently determined by the night/day ratio of UNaV (r = -0.55, p < 0.0001), not renal function or BP.

Conclusions:

  • Circadian rhythm of natriuresis is influenced by renal function and blood pressure.
  • Circadian rhythm of urinary potassium excretion is primarily determined by urinary sodium excretion, independent of renal function or blood pressure in CKD.
Abstract

Related Concept Videos

One-Compartment Open Model: Urinary Excretion Data and Determination of k01:11

One-Compartment Open Model: Urinary Excretion Data and Determination of k

The one-compartment open model leverages urinary excretion data to estimate renal clearance, which gauges the kidney's capacity to expel a drug. This method offers several benefits, including directly measuring drug elimination and assessing the kidney's contribution to overall drug clearance. However, this approach has limitations. It assumes sole renal excretion of the drug, which is not true for all drugs. Accurate urinary excretion and plasma drug concentration measurement can also be...
Renal Drug Excretion: Tubular Reabsorption01:25

Renal Drug Excretion: Tubular Reabsorption

Tubular reabsorption, a process occurring post-glomerular filtration of drugs in the renal tubule, is a critical determinant of drug half-life. During the process of renal excretion, as the glomerular filtrate progresses to the distal convoluted tubule (DCT), drugs that are highly permeable, lipophilic, and nonionized undergo passive reabsorption from the tubular fluid into the surrounding peritubular capillaries. This reabsorption process restricts their elimination through the kidneys. This...
Renal Drug Excretion: Effect of Urine pH, Flow Rate, and Drug pKa01:22

Renal Drug Excretion: Effect of Urine pH, Flow Rate, and Drug pKa

The pH of urine, the drug's pKa, and the urine flow rate are vital parameters for drug reabsorption and excretion. Urinary pH varies between 4.6 and 8.0 and is influenced by diet, drug intake, and the patient's pathophysiology. It affects a drug's ionization state and reabsorption. For instance, carbohydrate-rich food produces alkaline urine promoting drug excretion, while proteins and certain medications like ascorbic acid lead to acidic urine enhancing reabsorption.
The pKa of a drug,...
Regulation of Sodium and Potassium01:26

Regulation of Sodium and Potassium

The regulation of sodium and potassium ion concentrations in the human body is a complex process governed primarily by hormones such as aldosterone, antidiuretic hormone (ADH), and atrial natriuretic peptide (ANP).
Sodium Regulation
Sodium ions make up approximately 90% of extracellular cations, with a normal blood plasma concentration of 136–148 mEq/L. A decrease in blood volume and pressure triggers the release of renin from granular cells in the juxtaglomerular complex (JGC), primarily in...
Antihypertensive Drugs: Potassium-Sparing Diuretics01:28

Antihypertensive Drugs: Potassium-Sparing Diuretics

Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...